Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Treasury Shares (2013 - 2014)

Scynexis' (SCYX) quarterly Treasury Shares came in at $17.8 million in Q1 2014, up 194.06% quarter-over-quarter from $6.1 million in Q4 2013.

Analysis

Scynexis (SCYX) Treasury Shares (2013 - 2014) Analysis & Trends

Scynexis (SCYX) has reported Treasury Shares for 2 consecutive years, with $17.8 million the latest figure, recorded in Q1 2014.

  • For the quarter ending Q1 2014, Treasury Shares changed N/A year-over-year to $17.8 million; the trailing twelve-month figure through Mar 2014 stood at $17.8 million (changed N/A YoY), and the FY2013 full-year result was $6.1 million, changed N/A from the prior year.
  • Treasury Shares advanced to $17.8 million in Q1 2014 per SCYX's latest filing, from $6.1 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $17.8 million in Q1 2014 and bottomed at $6.1 million in Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Scynexis 58.41 Mn -56.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 17.80 Mn
Mar 31, 2014 17.80 Mn
Dec 31, 2013 6.05 Mn
Dec 31, 2013 6.05 Mn